Patents by Inventor Naim Sayag

Naim Sayag has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • RASAGILINE FOR PARKINSON'S DISEASE MODIFICATION
    Publication number: 20140243418
    Abstract: A method for modifying Parkinson's disease by periodically administering a pharmaceutical composition comprising a therapeutically effective amount of rasagiline or a pharmaceutically acceptable salt of rasagiline to the patient, thereby modifying the disease. The method includes reducing the rate of progression; delaying the need for symptomatic anti-Parkinsonian therapy; reducing the risk of a Parkinson's disease patient requiring symptomatic anti-Parkinsonian therapy; and reducing the functional decline.
    Type: Application
    Filed: November 27, 2013
    Publication date: August 28, 2014
    Applicant: Teva Pharmaceutical Industries, Ltd.
    Inventors: Ruth Levy, Eli Eyal, Tamar Goren, Sheila Oren, Naim Sayag, Yonatan Weiss, Miri Ben-Ami
  • Rasagiline for parkinson's disease modification
    Publication number: 20090312436
    Abstract: A method for modifying Parkinson's disease by periodically administering a pharmaceutical composition comprising a therapeutically effective amount of rasagiline or a pharmaceutically acceptable salt of rasagiline to the patient, thereby modifying the disease. The method includes reducing the rate of progression; delaying the need for symptomatic anti-Parkinsonian therapy; reducing the risk of a Parkinson's disease patient requiring symptomatic anti-Parkinsonian therapy; and reducing the functional decline.
    Type: Application
    Filed: June 12, 2009
    Publication date: December 17, 2009
    Inventors: Ruth Levy, Eli Eyal, Tamar Goren, Sheila Oren, Naim Sayag, Yonatan Weiss, Miri Ben-Ami
  • Dual release formulation comprising levodopa ethyl ester and a decarboxylase inhibitor in an immediate-release layer with levodopa ethyl ester in a controlled release core
    Publication number: 20030152628
    Abstract: A tablet which comprises
    Type: Application
    Filed: July 12, 2002
    Publication date: August 14, 2003
    Inventors: Daniela Licht, Shulamit Patashnik, Ezmira Naftali, Naim Sayag, Adrian Gilbert, Sasson Cohen, Corinne Zollmann
  • Dual release formulation comprising levodopa ethyl ester and a decarboxylase inhibitor in immediate release layer with levodopa ethyl ester and a decarboxylase inhibitor in a controlled release core
    Publication number: 20030147957
    Abstract: A tablet which comprises:
    Type: Application
    Filed: July 12, 2002
    Publication date: August 7, 2003
    Inventors: Daniela Licht, Shulamit Patashnik, Ezmira Naftali, Naim Sayag, Adrian Gilbert, Sasson Cohen, Corinne Zollmann
  • Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives
    Patent number: 5880159
    Abstract: Novel derivatives of 1-aminoindan and their salts are described. Optically active 1-aminoindan derivatives are prepared by reacting a N-benzyl analog of the desired compound with an enantiomer of mandelic acid.
    Type: Grant
    Filed: October 9, 1997
    Date of Patent: March 9, 1999
    Assignees: Teva Pharmaceutical Industries, Ltd., Technion Research and Development Foundation, Ltd.
    Inventors: Yaacov Herzig, Jeff Sterling, Alex Veinberg, Moussa B. H. Youdim, John P. M. Finberg, Naim Sayag